2022
Human papillomavirus 16/18/45 are not the most frequent genotypes in African American women: analysis in cervical Papanicolaou smears of women in an inner-city hospital
Dababneh M, Birdsong G, Mosunjac M, Krishnamurti U. Human papillomavirus 16/18/45 are not the most frequent genotypes in African American women: analysis in cervical Papanicolaou smears of women in an inner-city hospital. Journal Of The American Society Of Cytopathology 2022, 12: 120-125. PMID: 36585313, DOI: 10.1016/j.jasc.2022.11.005.Peer-Reviewed Original ResearchConceptsHR-HPV genotypesAfrican American womenIntraepithelial lesionsPap testHigh-grade squamous intraepithelial lesion casesHigh-grade squamous intraepithelial lesionsCommon high-risk HPVHPV molecular testingHigh-risk HPVSquamous intraepithelial lesionsCervical Pap testBethesda classification systemCommon human papillomavirusCervical Papanicolaou smearsInner-city hospitalSecondary prevention methodsAmerican womenHR-HPVHPV vaccineHPV genotypesCervical cancerHuman papillomavirusPapanicolaou smearsAfrican American populationLesion cases
2021
Evaluating the Impact of Wellness Days on Enrollment of Underserved Women in the Connecticut Early Detection and Prevention Program
Pratte MA, Ogazi C, Vozzolo C, Wright D, Griffin A. Evaluating the Impact of Wellness Days on Enrollment of Underserved Women in the Connecticut Early Detection and Prevention Program. Health Promotion Practice 2021, 23: 375-377. PMID: 33969727, DOI: 10.1177/15248399211013814.Peer-Reviewed Original ResearchConceptsWellness daysPrevention programsEarly detectionChronic disease preventionPreventive health servicesEssential preventive servicesOngoing evaluation effortsUnderserved womenPapanicolaou testPreventive servicesChronic diseasesCardiovascular diseaseWomen's healthHealth educationDisease preventionHealth servicesFederal poverty thresholdWomenUnderserved communitiesMinority womenHealth assessmentDiseaseDaysHealthCancerHigh-Risk Human Papillomavirus Testing, Genotyping, and Histopathologic Follow-up in Women With Abnormal Glandular Cells on Papanicolaou Tests
Zuo T, Levi AW, Lin Q, Abi-Raad R, Adeniran AJ, Cai G. High-Risk Human Papillomavirus Testing, Genotyping, and Histopathologic Follow-up in Women With Abnormal Glandular Cells on Papanicolaou Tests. American Journal Of Clinical Pathology 2021, 156: 569-576. PMID: 33728437, DOI: 10.1093/ajcp/aqaa265.Peer-Reviewed Original ResearchConceptsPositive hrHPV resultsCervical intraepithelial neoplasiaHrHPV resultsHrHPV testingCIN2-3Intraepithelial neoplasiaPapanicolaou testCervical carcinomaHigh risk human papillomavirus statusHigh-risk human papillomavirus (hrHPV) testingHigh-grade cervical intraepithelial neoplasiaLow-grade cervical intraepithelial neoplasiaHuman papillomavirus testingHuman papillomavirus (HPV) statusManagement of patientsAbnormal glandular cellsHPV genotypesHPV subtypesAGC casesPap testFollow-upHistologic followHigh lesionsType 16Reactive changes
2020
Mapping the cervical cancer screening cascade among women living with HIV in Johannesburg, South Africaa
Rohner E, Mulongo M, Pasipamire T, Oberlin A, Goeieman B, Williams S, Lubeya M, Rahangdale L, Chibwesha C. Mapping the cervical cancer screening cascade among women living with HIV in Johannesburg, South Africaa. International Journal Of Gynecology & Obstetrics 2020, 152: 53-59. PMID: 33188707, DOI: 10.1002/ijgo.13485.Peer-Reviewed Original ResearchConceptsPap resultsSuspected cancerElectronic medical record systemMedical record systemProportion of womenAbnormal Pap resultsCytology screening programsCare cascadeScreening outcomesRetrospective cohort studyCervical screeningScreening programSouth African womenClinical guidelinesCohort studyPap smear resultsPublic sector programsRecording systemHIVColposcopic biopsyWomenSmear resultsAfrican womenCumulative incidenceCervical cancerDo High Rates of Atypical Glandular Cells Correlate With Higher Incidence of Disease in a Large Safety Net Hospital.
Kuhn T, Finneran C, Kohut A, Wang E, Birdsong G, Krishnamurti U, Mosunjac M, Tadros T, Oprea G, Avadhani V, Boguslawski S, Karlow S, Schnatz P, Khanna N, Flowers L. Do High Rates of Atypical Glandular Cells Correlate With Higher Incidence of Disease in a Large Safety Net Hospital. Journal Of Lower Genital Tract Disease 2020, 24: 353-357. PMID: 32569024, DOI: 10.1097/lgt.0000000000000556.Peer-Reviewed Original ResearchConceptsAGC Pap testsAbnormal uterine bleedingPap testUterine bleedingHPV positivityHuman papillomavirusLarge safety net hospitalBody mass indexHigh-risk lesionsLow-risk lesionsSafety-net hospitalLow socioeconomic statusBaseline characteristicsEndometrial biopsyMass indexSingle institutionMedical recordsNet hospitalHigh incidencePatientsLesionsSignificant associationHR lesionsBleedingLogistic regression
2019
Knowledge of, and beliefs about, access to screening facilities and cervical cancer screening behaviors among low-income women in New Jersey
Silvera SAN, Bandera EV, Jones BA, Kaplan AM, Demisse K. Knowledge of, and beliefs about, access to screening facilities and cervical cancer screening behaviors among low-income women in New Jersey. Cancer Causes & Control 2019, 31: 43-49. PMID: 31720918, PMCID: PMC9083372, DOI: 10.1007/s10552-019-01244-5.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedCross-Sectional StudiesEarly Detection of CancerEthnicityFemaleHealth Knowledge, Attitudes, PracticeHealth Services AccessibilityHealth Status DisparitiesHealthcare DisparitiesHumansLogistic ModelsMass ScreeningMiddle AgedMultivariate AnalysisNew JerseyPapanicolaou TestPovertyRacial GroupsRiskUterine Cervical NeoplasmsVaginal SmearsYoung AdultConceptsLow-income womenCervical cancerCancer outcomesCervical cancer outcomesMultivariate logistic regressionCross-sectional studyPap testingPap testCancer screeningInsurance statusCancer testsPrevention strategiesEthnic disparitiesLogistic regressionSocioeconomic differencesCancerWomenAffordable screeningScreening facilityScreeningOutcomesRisk awarenessNew JerseyYearsCompliance with cervical cancer screening guidelines in young female patients: rates and trends of screening in New Haven County, CT
Oliveira CR, Hosier H, Pate B, Niccolai LM, Sheth SS, Vash-Margita A. Compliance with cervical cancer screening guidelines in young female patients: rates and trends of screening in New Haven County, CT. American Journal Of Obstetrics And Gynecology 2019, 221: 530-532. PMID: 31279847, PMCID: PMC6829042, DOI: 10.1016/j.ajog.2019.07.002.Peer-Reviewed Original ResearchLimitations in Correspondence Programs for Cervical Cancer Screening: Who Are the Women We Are Missing?
Clark M, Lee A, Kupets R. Limitations in Correspondence Programs for Cervical Cancer Screening: Who Are the Women We Are Missing? Journal Of Obstetrics And Gynaecology Canada 2019, 41: 1410-1415. PMID: 30803876, DOI: 10.1016/j.jogc.2018.11.034.Peer-Reviewed Original ResearchConceptsPrimary care physiciansCare physiciansHealth care encountersCervical cancerCare encountersMore health care encountersRetrospective observational studyCervical cancer screeningHealth care servicesBasis of ageEligible womenCancer screeningAdministrative databasesObservational studyScreening programCare servicesHealth servicesPhysiciansCorrespondence programWomenFurther riskOutreach methodsCancerMailingInfrequent usersCervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Clark R, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network 2019, 17: 64-84. PMID: 30659131, DOI: 10.6004/jnccn.2019.0001.Peer-Reviewed Original ResearchMeSH KeywordsAntineoplastic Combined Chemotherapy ProtocolsBrachytherapyCervix UteriChemoradiotherapy, AdjuvantFemaleFertility PreservationHumansHysterectomyMass ScreeningMedical OncologyNeoplasm StagingOrgan Sparing TreatmentsPapanicolaou TestPapillomaviridaePapillomavirus InfectionsSocieties, MedicalUnited StatesUterine Cervical NeoplasmsConceptsCervical cancerHuman papilloma virus vaccinationNCCN Clinical Practice GuidelinesTreatment of recurrentAdvanced cervical cancerClinical practice guidelinesMalignant epithelial tumorsNCCN guidelinesMetastatic diseaseVirus vaccinationUterine cervixCommon cancerPrecancerous lesionsFull guidelinePractice guidelinesEpithelial tumorsRoutine screeningCancerScreening protocolTreatmentGuidelinesMost casesEarly stagesCervixVaccination
2017
Cytologic predictors of malignancy in bile duct brushings: a multi-reviewer analysis of 60 cases
Avadhani V, Hacihasanoglu E, Memis B, Pehlivanoglu B, Hanley K, Krishnamurti U, Krasinskas A, Osunkoya A, Daniels L, Freedman A, Goodman M, Adsay V, Reid M. Cytologic predictors of malignancy in bile duct brushings: a multi-reviewer analysis of 60 cases. Modern Pathology 2017, 30: 1273-1286. PMID: 28664934, DOI: 10.1038/modpathol.2017.51.Peer-Reviewed Original Research
2015
Prevalence and risk factors of cervical squamous intraepithelial lesions among HIV-infected women in Dar es Salaam, Tanzania
Liu E, McCree R, Mtisi E, Fawzi WW, Aris E, Lema IA, Hertzmark E, Chalamilla G, Li N, Vermund SH, Spiegelman D. Prevalence and risk factors of cervical squamous intraepithelial lesions among HIV-infected women in Dar es Salaam, Tanzania. International Journal Of STD & AIDS 2015, 27: 219-225. PMID: 25957324, PMCID: PMC11340030, DOI: 10.1177/0956462415584466.Peer-Reviewed Original ResearchConceptsCervical squamous intraepithelial lesionsSquamous intraepithelial lesionsHIV disease stageCell countIntraepithelial lesionsDisease stageHigh-grade squamous intraepithelial lesionsAdvanced HIV disease stageCervical cancer prevention servicesLow CD4 cell countsCD4 cell countCancer prevention servicesCross-sectional studyResource-limited settingsCervical inflammationLow CD4Median CD4HIV careMedian ageCervical screeningPapanicolaou smearsRisk factorsTreatment clinicsPrevention servicesHIV
2014
Prior High-Risk Human Papillomavirus Testing and Papanicolaou Test Results of 70 Invasive Cervical Carcinomas Diagnosed in 2012: Results of a Retrospective Multicenter Study
Zhao C, Li Z, Nayar R, Levi AW, Winkler BA, Moriarty AT, Barkan GA, Rao J, Miller F, Fan F, Zhou Z, Si Q, Fischer AH, Sturgis CD, Jing X, Marshall CB, Witt BL, Birdsong GG, Crothers BA. Prior High-Risk Human Papillomavirus Testing and Papanicolaou Test Results of 70 Invasive Cervical Carcinomas Diagnosed in 2012: Results of a Retrospective Multicenter Study. Archives Of Pathology & Laboratory Medicine 2014, 139: 184-8. PMID: 24694342, DOI: 10.5858/arpa.2014-0028-oa.Peer-Reviewed Original ResearchConceptsInvasive cervical cancerInvasive cervical carcinomaHrHPV testingCervical cancerCervical carcinomaHPV testingHistologic diagnosisPersistent high-risk human papillomavirus (HPV) infectionHigh-risk human papillomavirus (hrHPV) testingHigh-risk human papillomavirus infectionHigh-risk HPV testingPrimary HPV testingHuman papillomavirus testingHuman papillomavirus infectionRetrospective multicenter studyCervical epithelial lesionsCurrent screening guidelinesSquamous cell carcinomaHPV ratesPapillomavirus infectionMulticenter studyScreening guidelinesCell carcinomaPapanicolaou testSingle institution
2012
Comparing Two Methods of Detection for Chlamydia trachomatis in Liquid-Based Papanicolaou Tests
Levi AW, Beckman D, Hui P, Schofield K, Harigopal M, Chhieng DC. Comparing Two Methods of Detection for Chlamydia trachomatis in Liquid-Based Papanicolaou Tests. American Journal Of Clinical Pathology 2012, 138: 236-240. PMID: 22904135, DOI: 10.1309/ajcp2b7xqtcnamjp.Peer-Reviewed Original ResearchConceptsHC2 assayBD Viper SystemXTR TechnologyPositive predictive valueDNA assaysLiquid-based Papanicolaou testsNucleic acidsC trachomatisChlamydia trachomatisPredictive valueHybrid Capture 2Reverse transcriptase-polymerase chain reactionChlamydia trachomatis testingTranscriptase-polymerase chain reactionViper SystemComparable specificityCapture 2Papanicolaou testChlamydial infectionCytology samplesMethod of detectionThinPrep specimensTrachomatisAssaysSensitivity rateObesity Disparities in Preventive Care: Findings From the National Ambulatory Medical Care Survey, 2005–2007
Hernandez‐Boussard T, Ahmed SM, Morton JM. Obesity Disparities in Preventive Care: Findings From the National Ambulatory Medical Care Survey, 2005–2007. Obesity 2012, 20: 1639-1644. PMID: 21818146, DOI: 10.1038/oby.2011.258.Peer-Reviewed Original ResearchMeSH KeywordsBody WeightDelivery of Health CareDietEarly Detection of CancerExerciseFemaleHealth Care SurveysHealth EducationHealthcare DisparitiesHumansMaleMammographyMental DisordersMiddle AgedNeoplasmsObesityObesity, MorbidOdds RatioPapanicolaou TestPhysical ExaminationPractice Patterns, Physicians'Preventive Health ServicesPsychotherapyReference ValuesReferral and ConsultationSmoking CessationVaginal SmearsWeight LossWounds and InjuriesConceptsNational Ambulatory Medical Care SurveyNormal weight patientsObese patientsWeight patientsPreventive careCancer screeningPractice patternsAmbulatory Medical Care SurveyPreventive health care servicesAdult patient visitsInjury prevention counselingHeight/weight dataIndex clinic visitClinic visit dataInjury prevention educationMajor health concernHealth care servicesPreventive health measuresClinic visitsObese populationPrevention counselingPreventive examsPsychotherapy referralsRectal examTobacco cessationDeveloping an integrated strategy to reduce ethnic and racial disparities in the delivery of clinical preventive services for older Americans.
Shenson D, Adams M, Bolen J, Wooten K, Clough J, Giles WH, Anderson L. Developing an integrated strategy to reduce ethnic and racial disparities in the delivery of clinical preventive services for older Americans. American Journal Of Public Health 2012, 102: e44-50. PMID: 22698041, PMCID: PMC3464841, DOI: 10.2105/ajph.2012.300701.Peer-Reviewed Original ResearchMeSH KeywordsAgedBehavioral Risk Factor Surveillance SystemBlack or African AmericanColonoscopyDelivery of Health Care, IntegratedFemaleHealth Services AccessibilityHealthcare DisparitiesHispanic or LatinoHumansMaleMammographyPapanicolaou TestPreventive Health ServicesVaccinationVaginal SmearsWhite PeopleConceptsClinical preventive servicesColorectal cancer screeningPapanicolaou testCancer screeningPreventive servicesBehavioral Risk Factor Surveillance SystemRisk Factor Surveillance SystemOlder AmericansPublic health focusRace/ethnicityOnly vaccinationPneumococcal vaccinationAdult immunizationSpecific vaccinationPrimary careHispanic adultsEthnic disparitiesHealth focusVaccinationRacial disparitiesSurveillance systemScreeningAdultsDisparitiesLevelsThe Positive Impact of Simultaneous Implementation of the BD FocalPoint GS Imaging System and Lean Principles on the Operation of Gynecologic Cytology
Wong R, Levi AW, Harigopal M, Schofield K, Chhieng DC. The Positive Impact of Simultaneous Implementation of the BD FocalPoint GS Imaging System and Lean Principles on the Operation of Gynecologic Cytology. Archives Of Pathology & Laboratory Medicine 2012, 136: 183-9. PMID: 22288966, DOI: 10.5858/arpa.2011-0139-oa.Peer-Reviewed Original ResearchCervical Cancer Prevention in Low- and Middle-Income Countries: Feasible, Affordable, Essential
Sahasrabuddhe VV, Parham GP, Mwanahamuntu MH, Vermund SH. Cervical Cancer Prevention in Low- and Middle-Income Countries: Feasible, Affordable, Essential. Cancer Prevention Research 2012, 5: 11-17. PMID: 22158053, PMCID: PMC3586242, DOI: 10.1158/1940-6207.capr-11-0540.Peer-Reviewed Original ResearchConceptsCervical cancer preventionHuman immunodeficiency virusCervical cancerMiddle-income countriesCancer preventionPrevention servicesCervical cancer prevention servicesCancer prevention servicesCervical cancer screeningGynecologic issuesImmunodeficiency virusHuman papillomavirusCancer screeningEarly treatmentPelvic examHigh-income countriesWorldwide burdenCare deliveryNew casesScreening testHPVCancerLMICsEffective alternativePrevention
2011
Implementation of FocalPoint GS location‐guided imaging system
Levi AW, Chhieng DC, Schofield K, Kowalski D, Harigopal M. Implementation of FocalPoint GS location‐guided imaging system. Cancer Cytopathology 2011, 120: 126-133. PMID: 22505211, DOI: 10.1002/cncy.20187.Peer-Reviewed Original ResearchConceptsASC-US casesHR-HPV positive rateLow-risk patient populationHigh-risk human papillomavirusASC-US interpretationsRoutine clinical settingPromising screening toolPap testHuman papillomavirusPapanicolaou testPatient populationBacterial vaginosisDrug AdministrationSIL ratioClinical settingScreening toolDiagnostic categoriesLaboratory information systemGynecologic cytologyPrimary screeningSignificant increaseFalse negative fractionPositive rateHigh percentageCurrent studyComparison of visual inspection with acetic acid and cervical cytology to detect high‐grade cervical neoplasia among HIV‐infected women in India
Sahasrabuddhe VV, Bhosale RA, Kavatkar AN, Nagwanshi CA, Joshi SN, Jenkins CA, Shepherd BE, Kelkar RS, Sahay S, Risbud AR, Vermund SH, Mehendale SM. Comparison of visual inspection with acetic acid and cervical cytology to detect high‐grade cervical neoplasia among HIV‐infected women in India. International Journal Of Cancer 2011, 130: 234-240. PMID: 21387289, PMCID: PMC3516675, DOI: 10.1002/ijc.25971.Peer-Reviewed Original ResearchMeSH KeywordsAcetatesAdultCervix UteriColposcopyCross-Sectional StudiesCytodiagnosisDNA, ViralFemaleHIVHIV InfectionsHumansIndiaMass ScreeningPapanicolaou TestPolymerase Chain ReactionPredictive Value of TestsSensitivity and SpecificityUterine Cervical DysplasiaUterine Cervical NeoplasmsVaginal SmearsConceptsCervical cytologyHigh-grade squamous intraepithelial lesionsHigh-grade cervical neoplasiaNegative predictive value estimatesScreening testHPV-positive CIN2Atypical squamous cellsSquamous intraepithelial lesionsHuman immunodeficiency virusConventional cervical cytologyPredictive value estimatesSecondary prevention methodsNonpregnant HIVRigorous endpointsAntiretroviral therapyHIV/Intraepithelial lesionsCervical neoplasiaCervical cancerImmunodeficiency virusSquamous cellsHuman papillomavirusUndetermined significanceIntraepithelial cellsCare programComparison of Affirm VPIII and Papanicolaou Tests in the Detection of Infectious Vaginitis
Levi AW, Harigopal M, Hui P, Schofield K, Chhieng DC. Comparison of Affirm VPIII and Papanicolaou Tests in the Detection of Infectious Vaginitis. American Journal Of Clinical Pathology 2011, 135: 442-447. PMID: 21350100, DOI: 10.1309/ajcp7tbn5vzuglzu.Peer-Reviewed Original ResearchConceptsAffirm VPIIIPap testPapanicolaou testRoutine Pap testRoutine Papanicolaou testCandida speciesSensitive diagnostic testInfectious vaginitisLarge academic institutionPatient populationTrichomonas infectionBacterial vaginosisCandida vaginitisG vaginalisT vaginalisStudy populationHigh incidenceDiagnostic testsMolecular testsPatientsVaginitisVaginalisMorphologic identificationVaginosisCandidiasis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply